In the complex landscape of global healthcare, access to essential medicines is a critical issue, especially for patients who require treatments that are not yet approved in their home countries.…
The process of importing unlicensed medicines through Named Patient Services involves several critical steps, each requiring meticulous attention to detail and adherence to regulatory standards...
In the evolving landscape of global healthcare, access to critical medicines remains a significant challenge, particularly for patients with rare or life-threatening conditions. Named Patient Medicine Programs (NPPs) have emerged…
